Market research
600511.SHG China National Medicines Corporation Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 20B
- P/E ratio
- 10.31
- Analyst target
- 36.43
- Dividend yield
- 3.0%
- Beta
- 0.14
Community
Investor discussion
1 comment
Sign in to join the 600511.SHG discussion.
5 years, 5 months ago
China National Medicines Corporation Ltd is currently in a long term downtrend where the price is trading 22.4% below its 200 day moving average.
From a valuation standpoint, the stock is 93.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
China National Medicines Corporation Ltd's total revenue sank by 5.6% to $11B since the same quarter in the previous year.
Its net income has dropped by 29.0% to $378M since the same quarter in the previous year.
Finally, its free cash flow grew by 25.9% to $847M since the same quarter in the previous year.
Based on the above factors, China National Medicines Corporation Ltd gets an overall score of 2/5.